Characteristics and Prognosis of Type 2 Myocardial Infarction Through Worsening Renal Function and NT-proBNP in Older Adults with Pneumonia

References

• Smer A, Squires RW, Aboeata A, et al. Type 2 myocardial infarction: current concepts and our experience with cardiac rehabilitation. J Cardiopulm Rehabil Prev. 2021;41(3):147–152. doi:10.1097/HCR.0000000000000550
   PubMed Web of Science ®Google Scholar
• Nestelberger T, Boeddinghaus J, Badertscher P, et al. Effect of definition on incidence and prognosis of type 2 myocardial infarction. J Am Coll Cardiol. 2017;70(13):1558–1568. doi:10.1016/j.jacc.2017.07.774
   PubMed Web of Science ®Google Scholar
• Sandoval Y, Jaffe AS. Type 2 myocardial infarction: JACC review topic of the week. J Am Coll Cardiol. 2019;73(14):1846–1860. doi:10.1016/j.jacc.2019.02.018
   PubMed Web of Science ®Google Scholar
• Singh A, Gupta A, DeFilippis EM, et al. Cardiovascular mortality after type 1 and type 2 myocardial infarction in young adults. J Am Coll Cardiol. 2020;75(9):1003–1013. doi:10.1016/j.jacc.2019.12.052
   PubMed Web of Science ®Google Scholar
• Chapman AR, Shah ASV, Lee KK, et al. Long-term outcomes in patients with type 2 myocardial infarction and myocardial injury. Circulation. 2018;137(12):1236–1245. doi:10.1161/CIRCULATIONAHA.117.031806
   PubMed Web of Science ®Google Scholar
• McCarthy CP, Kolte D, Kennedy KF, et al. Patient characteristics and clinical outcomes of type 1 versus type 2 myocardial infarction. J Am Coll Cardiol. 2021;77(7):848–857. doi:10.1016/j.jacc.2020.12.034
   PubMed Web of Science ®Google Scholar
• Wereski R, Kimenai DM, Bularga A, et al. Risk factors for type 1 and type 2 myocardial infarction. Eur Heart J. 2022;43(2):127–135. doi:10.1093/eurheartj/ehab581
   PubMed Web of Science ®Google Scholar
• Raphael CE, Roger VL, Sandoval Y, et al. Incidence, trends, and outcomes of type 2 myocardial infarction in a community cohort. Circulation. 2020;141(6):454–463. doi:10.1161/CIRCULATIONAHA.119.043100
   PubMed Web of Science ®Google Scholar
• Tripathi B, Tan BE, Sharma P, et al. Characteristics and outcomes of patients admitted with type 2 myocardial infarction. Am J Cardiol. 2021;157:33–41. doi:10.1016/j.amjcard.2021.07.013
   PubMed Web of Science ®Google Scholar
• Neumann JT, Weimann J, Sörensen NA, et al. A biomarker model to distinguish types of myocardial infarction and injury. J Am Coll Cardiol. 2021;78(8):781–790. doi:10.1016/j.jacc.2021.06.027
   PubMed Web of Science ®Google Scholar
• McCarthy CP, Vaduganathan M, Singh A, et al. Type 2 myocardial infarction and the hospital readmission reduction program. J Am Coll Cardiol. 2018;72(10):1166–1170. doi:10.1016/j.jacc.2018.06.055
   PubMed Web of Science ®Google Scholar
• Nestelberger T, Boeddinghaus J, Lopez-Ayala P, et al. Cardiovascular biomarkers in the early discrimination of type 2 myocardial infarction. JAMA Cardiol. 2021;6(7):771–780. doi:10.1001/jamacardio.2021.0669
   PubMed Web of Science ®Google Scholar
• Putot A, Jeanmichel M, Chague F, et al. Type 2 myocardial infarction: a geriatric population-based model of pathogenesis. Aging Dis. 2020;11(1):108–117. doi:10.14336/AD.2019.0405
   PubMed Web of Science ®Google Scholar
• Gaggin HK, Liu Y, Lyass A, et al. Incident type 2 myocardial infarction in a cohort of patients undergoing coronary or peripheral arterial angiography. Circulation. 2017;135(2):116–127. doi:10.1161/CIRCULATIONAHA.116.023052
   PubMed Web of Science ®Google Scholar
• Hung J, Roos A, Kadesjö E, et al. Performance of the GRACE 2.0 score in patients with type 1 and type 2 myocardial infarction. Eur Heart J. 2021;42(26):2552–2561. doi:10.1093/eurheartj/ehaa375
   PubMed Web of Science ®Google Scholar
• McCarthy CP, Vaduganathan M, Januzzi JL. Type 2 myocardial infarction-diagnosis, prognosis, and treatment. JAMA. 2018;320(5):433–434. doi:10.1001/jama.2018.7125
   PubMed Web of Science ®Google Scholar
• McCarthy CP. Type 2 myocardial infarction and value-based programs: cutting the supply in the absence of demand. Am J Med. 2019;132(10):1117–1118. doi:10.1016/j.amjmed.2019.02.037
   PubMed Web of Science ®Google Scholar
• Thygesen K, Jaffe AS. The gloomy long-term prognosis of patients with type 2 myocardial infarction or myocardial injury. J Am Coll Cardiol. 2020;75(9):1014–1016. doi:10.1016/j.jacc.2020.01.004
   PubMed Web of Science ®Google Scholar
• Oblavatckii DV, Boldueva SA, Soloveva MV, et al. The frequency of type 2 myocardial infarction in the structure of hospital mortality according to 7-years data of a state university clinic. Kardiologiia. 2020;60(6):896. doi:10.18087/cardio.2020.6.n896
   PubMed Web of Science ®Google Scholar
• Rasla S, Thabet R. The prognostic yield of type 2 myocardial infarction. J Am Coll Cardiol. 2020;76(3):353. doi:10.1016/j.jacc.2020.03.089
   PubMed Web of Science ®Google Scholar
• McCarthy CP, Murphy S, Cohen JA, et al. Sex differences in patient characteristics, treatment strategies, and outcomes for type 2 myocardial infarction. J Am Coll Cardiol. 2019;73(24):3230–3232. doi:10.1016/j.jacc.2019.04.016
   PubMed Web of Science ®Google Scholar
• Hoang TH, Lazarev PV, Maiskov VV, et al. Concordance and prognostic relevance of angiographic and clinical definitions of myocardial infarction type. J Cardiovasc Pharmacol Ther. 2021;26(5):463–472. doi:10.1177/10742484211005929
   PubMed Web of Science ®Google Scholar
• Mohamed MO, Contractor T, Abramov D, et al. Sex-based differences in prevalence and outcomes of common acute conditions associated with type 2 myocardial infarction. Am J Cardiol. 2021;147:8–15. doi:10.1016/j.amjcard.2021.02.011
   PubMed Web of Science ®Google Scholar
• Navarra S, Solini A, Baroni MG, et al. A long-term nationwide study on chronic kidney disease-related mortality in Italy: trends and associated comorbidity. J Nephrol. 2022;35(2):505–515. doi:10.1007/s40620-021-01132-9
   PubMed Web of Science ®Google Scholar
• Zhang XM, Wu XJ, Cao J, et al. Effect of the age-adjusted Charlson comorbidity index on all-cause mortality and readmission in older surgical patients: a national multicenter, prospective cohort study. Front Med. 2022;9:896451. doi:10.3389/fmed.2022.896451
   Web of Science ®Google Scholar
• Adamo M, Pagnesi M, Mebazaa A, et al. NT-proBNP and high-intensity care for acute heart failure: the STRONG-HF trial. Eur Heart J. 2023;44(31):2947–2962. doi:10.1093/eurheartj/ehad335
   PubMed Web of Science ®Google Scholar
• Shah ASV, Sandoval Y, Noaman A, et al. Patient selection for high sensitivity cardiac troponin testing and diagnosis of myocardial infarction: prospective cohort study. BMJ. 2017;359:j4788. doi:10.1136/bmj.j4788
   PubMed Web of Science ®Google Scholar
• DeFilippis AP, Chapman AR, Mills NL, et al. Assessment and treatment of patients with type 2 myocardial infarction and acute nonischemic myocardial injury. Circulation. 2019;140(20):1661–1678. doi:10.1161/CIRCULATIONAHA.119.040631
   PubMed Web of Science ®Google Scholar
• Kimenai DM, Lindahl B, Chapman AR, et al. Sex differences in investigations and outcomes among patients with type 2 myocardial infarction. Heart. 2021;107(18):1480–1486. doi:10.1136/heartjnl-2021-319118
   PubMed Web of Science ®Google Scholar
• McCarthy CP, Murphy S, Rehman S, et al. Home-time after discharge among patients with type 2 myocardial infarction. J Am Heart Assoc. 2020;9(10):e015978. doi:10.1161/JAHA.119.015978
   PubMed Web of Science ®Google Scholar
• Lambrakis K, French JK, Scott IA, et al. The appropriateness of coronary investigation in myocardial injury and type 2 myocardial infarction (ACT-2): a randomized trial design. Am Heart J. 2019;208:11–20. doi:10.1016/j.ahj.2018.09.016
   PubMed Web of Science ®Google Scholar
• Arora S, Strassle PD, Qamar A, et al. Impact of type 2 myocardial infarction (MI) on hospital-level MI outcomes: implications for quality and public reporting. J Am Heart Assoc. 2018;7(7):e008661. doi:10.1161/JAHA.118.008661
   PubMed Web of Science ®Google Scholar
• De Luca L, Cappadona F, Temporelli PL, et al. Impact of eGFR rate on 1-year all-cause mortality in patients with stable coronary artery disease. Eur J Intern Med. 2022;101:98–105. doi:10.1016/j.ejim.2022.04.021
   PubMed Web of Science ®Google Scholar
• Núñez J, de la Espriella R, Rossignol P, et al. Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology. Eur J Heart Fail. 2022;24(10):1751–1766. doi:10.1002/ejhf.2664
   PubMed Web of Science ®Google Scholar
• Jia X, Al Rifai M, Hoogeveen R, et al. Association of long-term change in N-Terminal Pro-B-Type natriuretic peptide with incident heart failure and death. JAMA Cardiol. 2023;8(3):222–230. doi:10.1001/jamacardio.2022.5309
   PubMed Web of Science ®Google Scholar
• Wang K, Zelnick LR, Anderson A, et al. Cardiac biomarkers and risk of mortality in CKD (the CRIC Study). Kidney Int Rep. 2020;5(11):2002–2012. doi:10.1016/j.ekir.2020.08.028
   PubMed Web of Science ®Google Scholar
• McCallum W, Tighiouart H, Kiernan MS, et al. Relation of kidney function decline and NT-proBNP with risk of mortality and readmission in acute decompensated heart failure. Am J Med. 2020;133(1):115–122.e2. doi:10.1016/j.amjmed.2019.05.047
   PubMed Web of Science ®Google Scholar
• Lorenzo M, Núñez G, Fuertes-Kenneally L, et al. The modifying role of admission renal function and decongestion. Eur J Intern Med. 2023;115:96–103.
   PubMed Web of Science ®Google Scholar
• Ariss RW, Minhas AMK, Nazir S, et al. Outcomes and resource utilization of atrial fibrillation hospitalizations with type 2 myocardial infarction. Am J Cardiol. 2021;152:27–33. doi:10.1016/j.amjcard.2021.04.036
   PubMed Web of Science ®Google Scholar
• Richter D, Guasti L, Koehler F, et al. Late phase of COVID-19 pandemic in general cardiology. A position paper of the ESC council for cardiology practice. ESC Heart Fail. 2021;8(5):3483–3494. doi:10.1002/ehf2.13466
   PubMed Web of Science ®Google Scholar
• Raphael CE, Roger VL, Sandoval Y, et al. Causes of death after type 2 myocardial infarction and myocardial injury. J Am Coll Cardiol. 2021;78(4):415–416. doi:10.1016/j.jacc.2021.05.026
   PubMed Web of Science ®Google Scholar